Cargando…

Mapping knowledge translation and innovation processes in Cancer Drug Development: the case of liposomal doxorubicin

We explored how the knowledge translation and innovation processes are structured when theyresult in innovations, as in the case of liposomal doxorubicin research. In order to map the processes, a literature network analysis was made through Cytoscape and semantic analysis was performed by GOPubmed...

Descripción completa

Detalles Bibliográficos
Autores principales: Fajardo-Ortiz, David, Duran, Luis, Moreno, Laura, Ochoa, Hector, Castaño, Victor M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4161884/
https://www.ncbi.nlm.nih.gov/pubmed/25182125
http://dx.doi.org/10.1186/s12967-014-0227-9
_version_ 1782334613975203840
author Fajardo-Ortiz, David
Duran, Luis
Moreno, Laura
Ochoa, Hector
Castaño, Victor M
author_facet Fajardo-Ortiz, David
Duran, Luis
Moreno, Laura
Ochoa, Hector
Castaño, Victor M
author_sort Fajardo-Ortiz, David
collection PubMed
description We explored how the knowledge translation and innovation processes are structured when theyresult in innovations, as in the case of liposomal doxorubicin research. In order to map the processes, a literature network analysis was made through Cytoscape and semantic analysis was performed by GOPubmed which is based in the controlled vocabularies MeSH (Medical Subject Headings) and GO (Gene Ontology). We found clusters related to different stages of the technological development (invention, innovation and imitation) and the knowledge translation process (preclinical, translational and clinical research), and we were able to map the historic emergence of Doxil as a paradigmatic nanodrug. This research could be a powerful methodological tool for decision-making and innovation management in drug delivery research.
format Online
Article
Text
id pubmed-4161884
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-41618842014-09-13 Mapping knowledge translation and innovation processes in Cancer Drug Development: the case of liposomal doxorubicin Fajardo-Ortiz, David Duran, Luis Moreno, Laura Ochoa, Hector Castaño, Victor M J Transl Med Research We explored how the knowledge translation and innovation processes are structured when theyresult in innovations, as in the case of liposomal doxorubicin research. In order to map the processes, a literature network analysis was made through Cytoscape and semantic analysis was performed by GOPubmed which is based in the controlled vocabularies MeSH (Medical Subject Headings) and GO (Gene Ontology). We found clusters related to different stages of the technological development (invention, innovation and imitation) and the knowledge translation process (preclinical, translational and clinical research), and we were able to map the historic emergence of Doxil as a paradigmatic nanodrug. This research could be a powerful methodological tool for decision-making and innovation management in drug delivery research. BioMed Central 2014-09-03 /pmc/articles/PMC4161884/ /pubmed/25182125 http://dx.doi.org/10.1186/s12967-014-0227-9 Text en © Fajardo-Ortiz et al.; licensee BioMed Central Ltd. 2014
spellingShingle Research
Fajardo-Ortiz, David
Duran, Luis
Moreno, Laura
Ochoa, Hector
Castaño, Victor M
Mapping knowledge translation and innovation processes in Cancer Drug Development: the case of liposomal doxorubicin
title Mapping knowledge translation and innovation processes in Cancer Drug Development: the case of liposomal doxorubicin
title_full Mapping knowledge translation and innovation processes in Cancer Drug Development: the case of liposomal doxorubicin
title_fullStr Mapping knowledge translation and innovation processes in Cancer Drug Development: the case of liposomal doxorubicin
title_full_unstemmed Mapping knowledge translation and innovation processes in Cancer Drug Development: the case of liposomal doxorubicin
title_short Mapping knowledge translation and innovation processes in Cancer Drug Development: the case of liposomal doxorubicin
title_sort mapping knowledge translation and innovation processes in cancer drug development: the case of liposomal doxorubicin
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4161884/
https://www.ncbi.nlm.nih.gov/pubmed/25182125
http://dx.doi.org/10.1186/s12967-014-0227-9
work_keys_str_mv AT fajardoortizdavid mappingknowledgetranslationandinnovationprocessesincancerdrugdevelopmentthecaseofliposomaldoxorubicin
AT duranluis mappingknowledgetranslationandinnovationprocessesincancerdrugdevelopmentthecaseofliposomaldoxorubicin
AT morenolaura mappingknowledgetranslationandinnovationprocessesincancerdrugdevelopmentthecaseofliposomaldoxorubicin
AT ochoahector mappingknowledgetranslationandinnovationprocessesincancerdrugdevelopmentthecaseofliposomaldoxorubicin
AT castanovictorm mappingknowledgetranslationandinnovationprocessesincancerdrugdevelopmentthecaseofliposomaldoxorubicin